A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer Cells
Binding studies. (a) Competition binding profile for AngII in D3H2LN-AT2 cells. Data are expressed as percentages of the maximum specific binding of the radioligand 3H-AngII. (b) Maximum binding obtained in the presence of the AT1 receptor antagonist (Losartan M) or AT2 receptor antagonist (PD123319 M), as compared to the control (vehicle). Values are means ± SE of three independent experiments done in duplicate.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.